Home
Previous
Next
November, 2014: 3 16
Disclaimer - IMPORTANT - Read this first!
| Investor's Journal is a diary focused strictly on investments and personal finance issues, primarily from a contrarian and retiree point of view. Follow along with an average guy's failures and successes as he learns, by trial and error, the fine art of value investing. |
11/3/14-Since the most recent prior entry and while the market was down, additional shares of REGI and VOD were purchased for the Low Price to Book Value portfolio.
Since 9/14/14, there have been no sell signals and no sales of assets followed here.
Alphabetically, my current top-five Low Price to Book Value equities are: KELYA; SCX; TA; UMC; and VOD.
My new featured Low Price to Book Value security is The L.S. Starrett Company (SCX) (recent price $14.98). SCX meets Benjamin Graham's bargain stock value and safety criteria.
The L.S. Starrett Company will be added to our nest egg at its market price in early morning trading on Tuesday, 11/4/14.
Alphabetically, my current top-five Dividend Value equities are: CATO; CPSI; CMTL; IQNT; and SPOK.
My new featured Dividend Value security is Inteliquent, Inc. (IQNT) (recent price $16.83). IQNT also meets Benjamin Graham's bargain stock value and safety criteria.
Shares of Inteliquent, Inc. as well will be added to our nest egg at its market price in early morning trading on Tuesday, 11/3/14.
11/16/14-No followed assets/portfolios have had sell signals or been sold since the last entry.
Research indicates that low price to sales is another good measure of equity value. While a low P/S ratio is not to my knowledge one of the official criteria suggested by Benjamin Graham, evidence over the past few decades suggests it may be an excellent, perhaps even more reliable, proxy for value than earnings yield or low P/Bk, each of which can in some instances be an inaccurate reflection of per share intrinsic value.
Not for the first time, nor likely to be the last, am starting a new experimental portfolio, this one based on the selection of good stocks with price to sales 0.5 or below.
Alphabetically, my current top-five Low Price to Sales equities are: CSH; KBAL; PZE; SCX; and UFS.
My featured initial Low Price to Sales security is Kimball International, Inc. (KBAL) (recent price $9.66). KBAL has a low P/S, relatively low P/Bk, a reasonably good return on equity, a dividend, and a safe dividend payout ratio level.
Kimball International, Inc. will be added to our nest egg at its market price in early morning trading on Monday, 11/17/14.
Disclaimer and Disclosure Statement
Neither I nor Investor's Journal will be responsible for losses by anyone who obtained ideas from this site.
This diary is intended for personal interest and general information only. You are advised to do your own research (as well as to consult highly compensated professionals) before spending money on anything.
I know of no reason anyone should take my financial musings seriously. At best I am a dedicated amateur providing a bit of investment-related insight and entertainment, at worst an amusing diversion.
My wife, Fran, and I may at times own shares of some of the assets mentioned here. But neither of us receive any benefit from reference to them, unless you count the mutual misery when we get it wrong, or the opportunity to gloat when we get it right.